Sale!

Cultured AFB Antitubercular DST Ethionamide Test

660 د.إ

-11%

The “Cultured AFB Antitubercular DST Ethionamide Test” is a specialized diagnostic procedure aimed at determining the susceptibility of Mycobacterium tuberculosis, the bacterium responsible for tuberculosis (TB), to the antibiotic ethionamide. This test is crucial for patients diagnosed with TB, as it helps in customizing the most effective treatment plan, particularly in cases where drug resistance is a concern.

Performed in sophisticated laboratory settings, such as DNA Labs UAE, this test involves culturing the patient’s sample to grow the tuberculosis bacteria, followed by exposing the bacteria to ethionamide to assess its effectiveness in inhibiting bacterial growth. The outcome of this test plays a vital role in guiding healthcare professionals to prescribe a treatment regimen that is most likely to be successful in combating the infection.

The cost of the Cultured AFB Antitubercular DST Ethionamide Test at DNA Labs UAE is set at 660 AED. Given the complexity and the critical role of this test in managing tuberculosis, especially multidrug-resistant strains, it represents a significant step towards personalized medicine in infectious disease management. Patients undergoing this test at DNA Labs UAE can expect comprehensive support, from sample collection to detailed analysis, ensuring accurate and reliable results that guide their treatment path.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CULTURED AFB ANTITUBERCULAR DST ETHIONAMIDE Test

At DNA Labs UAE, we offer the CULTURED AFB ANTITUBERCULAR DST ETHIONAMIDE test at a cost of AED 660.0. This test is used to determine the susceptibility of Mycobacterium tuberculosis to the drug ethionamide.

Test Components and Price

Test Name: CULTURED AFB ANTITUBERCULAR DST ETHIONAMIDE Test

Price: 660.0 AED

Sample Condition

Submit a pure growth of Mycobacterium tuberculosis complex on appropriate media in a sterile screw-capped container in a sealed plastic bag. Ship refrigerated or, when used with other AFB culture or Mycobacteria identification tests, the pure growth obtained in the Laboratory from specimens already submitted will be processed for Antitubercular Sensitivity.

Report Delivery

Sample: Daily by 3.30 pm

Report: 21 days

Method

Automated Fluorescent

Test Type

Tuberculosis

Doctor

Physician

Test Department

Pre Test Information: No special preparation required

Test Details

The Cultured AFB Antitubercular DST (Drug Susceptibility Testing) for Ethionamide is a laboratory test used to determine the susceptibility of Mycobacterium tuberculosis to the drug ethionamide. Ethionamide is an antibiotic used in the treatment of tuberculosis (TB) and is part of the second-line drug regimen for drug-resistant TB.

The test involves culturing the Mycobacterium tuberculosis bacteria obtained from a patient’s sputum or other clinical samples. The cultured bacteria are then exposed to different concentrations of ethionamide to determine the minimum inhibitory concentration (MIC) required to inhibit their growth. The MIC is the lowest concentration of the drug that prevents visible growth of the bacteria.

The results of the Cultured AFB Antitubercular DST for Ethionamide will determine whether the strain of Mycobacterium tuberculosis is susceptible or resistant to ethionamide. Susceptible strains will be inhibited by the drug at clinically achievable concentrations, indicating that ethionamide can be used effectively in the treatment of the patient’s TB. On the other hand, resistant strains will continue to grow even at high concentrations of ethionamide, indicating that alternative drugs or drug combinations need to be used for effective treatment.

This test is important in guiding the selection of appropriate drugs for the treatment of TB, especially in cases of drug-resistant strains. It helps in determining the most effective drug regimen to ensure successful treatment outcomes and prevent the development of further drug resistance.

Test Name CULTURED AFB ANTITUBERCULAR DST ETHIONAMIDE Test
Components
Price 660.0 AED
Sample Condition Submit pure growth ofMycobacterium tuberculosis complexon appropriate media in sterile screw capped container in a sealed plastic bag. Ship refrigerated ORwhen used with other AFB culture or Mycobacteria identification tests, the pure growth obtained in the Laboratory from specimens already submittedwill be processed for Antitubercular Sensitivity.
Report Delivery Sample Daily by 3.30 pm; Report 21 days
Method Automated Fluorescent
Test type Tuberculosis
Doctor Physician
Test Department:
Pre Test Information No special preparation required
Test Details

The Cultured AFB Antitubercular DST (Drug Susceptibility Testing) for Ethionamide is a laboratory test used to determine the susceptibility of Mycobacterium tuberculosis to the drug ethionamide. Ethionamide is an antibiotic used in the treatment of tuberculosis (TB) and is part of the second-line drug regimen for drug-resistant TB.

The test involves culturing the Mycobacterium tuberculosis bacteria obtained from a patient’s sputum or other clinical samples. The cultured bacteria are then exposed to different concentrations of ethionamide to determine the minimum inhibitory concentration (MIC) required to inhibit their growth. The MIC is the lowest concentration of the drug that prevents visible growth of the bacteria.

The results of the Cultured AFB Antitubercular DST for Ethionamide will determine whether the strain of Mycobacterium tuberculosis is susceptible or resistant to ethionamide. Susceptible strains will be inhibited by the drug at clinically achievable concentrations, indicating that ethionamide can be used effectively in the treatment of the patient’s TB. On the other hand, resistant strains will continue to grow even at high concentrations of ethionamide, indicating that alternative drugs or drug combinations need to be used for effective treatment.

This test is important in guiding the selection of appropriate drugs for the treatment of TB, especially in cases of drug-resistant strains. It helps in determining the most effective drug regimen to ensure successful treatment outcomes and prevent the development of further drug resistance.